AR019279A1 - Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion. - Google Patents
Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion.Info
- Publication number
- AR019279A1 AR019279A1 ARP990102177A ARP990102177A AR019279A1 AR 019279 A1 AR019279 A1 AR 019279A1 AR P990102177 A ARP990102177 A AR P990102177A AR P990102177 A ARP990102177 A AR P990102177A AR 019279 A1 AR019279 A1 AR 019279A1
- Authority
- AR
- Argentina
- Prior art keywords
- procedure
- preparation
- salts
- pharmaceutically applicable
- oral application
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Forma medicamentosa solida de estructura polifásica para aplicacion oral, que consiste en gatifloxacina o sus sales o hidratos farmacéuticamente aplicables, y auxiliares elegidos del grupo que comprende cargas, aglutinantes, lubricantes, promotoresd e disgregacion o sus mezclas, que comprende una fase interior quecontiene la sustancia activa gatifloxacina o sus sales o hidratos farmacéuticamente aplicables, auxiliares elegidos del grupo que comprende aglutinantes,cargas, promotores dedisgregaci on o sus mezclas, y al menos una fase exterior que contiene como componente necesario al menos un promotor de disgregacion, yotros auxiliares elegidos del grupo que comprende al menos un lubricante, y eventualmente cargas y/oeventualmente aglutinant es. Procedimietno para lapreparacion de la forma medicamentosa solida.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19820801A DE19820801A1 (de) | 1998-05-09 | 1998-05-09 | Orale Arzneiformen mit reproduzierbarer Wirkstofffreisetzung von Gatifloxacin oder pharmazeutisch verwendbaren Salzen oder Hydraten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR019279A1 true AR019279A1 (es) | 2002-02-13 |
Family
ID=7867223
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990102177A AR019279A1 (es) | 1998-05-09 | 1999-05-07 | Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion. |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6291462B1 (es) |
| EP (1) | EP1077703B1 (es) |
| JP (1) | JP2002514600A (es) |
| KR (1) | KR100587210B1 (es) |
| CN (1) | CN1198615C (es) |
| AR (1) | AR019279A1 (es) |
| AT (1) | ATE235242T1 (es) |
| AU (1) | AU753482B2 (es) |
| BR (1) | BR9910350A (es) |
| CA (1) | CA2325636A1 (es) |
| CO (1) | CO5050341A1 (es) |
| DE (2) | DE19820801A1 (es) |
| DK (1) | DK1077703T3 (es) |
| ES (1) | ES2195573T3 (es) |
| HK (1) | HK1033281A1 (es) |
| HU (1) | HUP0101597A3 (es) |
| IL (1) | IL139512A0 (es) |
| MY (1) | MY118569A (es) |
| NO (1) | NO20005385L (es) |
| NZ (1) | NZ507968A (es) |
| PE (1) | PE20000480A1 (es) |
| PL (1) | PL343936A1 (es) |
| PT (1) | PT1077703E (es) |
| RU (1) | RU2226394C2 (es) |
| SK (1) | SK16772000A3 (es) |
| UA (1) | UA60364C2 (es) |
| WO (1) | WO1999058129A1 (es) |
| ZA (1) | ZA200006440B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL148820A0 (en) * | 1999-10-08 | 2002-09-12 | Smithkline Beecham Corp | Fab i inhibitors |
| US6413969B1 (en) * | 2000-09-13 | 2002-07-02 | Bristol-Myers Squibb Company | Gatifloxacin pentahydrate |
| AU2002367773A1 (en) * | 2001-04-06 | 2003-11-03 | Affinium Pharmaceuticals, Inc. | Fab i inhibitors |
| US6589955B2 (en) * | 2001-06-20 | 2003-07-08 | Bristol-Myers Squibb Company | Pediatric formulation of gatifloxacin |
| US7790709B2 (en) | 2002-12-06 | 2010-09-07 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
| WO2004082586A2 (en) | 2003-03-17 | 2004-09-30 | Affinium Pharmaceuticals, Inc. | Phamaceutical compositions comprising inhibitors of fab i and further antibiotics |
| US20050031683A1 (en) * | 2003-08-04 | 2005-02-10 | Ashish Kapoor | Solid pharmaceutical composition |
| WO2005021000A1 (en) * | 2003-08-28 | 2005-03-10 | Ranbaxy Laboratories Limited | Solid oral dosage forms of gatifloxacin |
| MY148773A (en) * | 2004-03-17 | 2013-05-31 | Novartis Ag | Galenic formulations of organic compounds |
| PT1828167E (pt) * | 2004-06-04 | 2014-10-08 | Debiopharm Int Sa | Derivados de acrilamida como agentes antibióticos |
| US20060247255A1 (en) * | 2005-05-02 | 2006-11-02 | Patel Satishkumar A | Method for preparing a stable gatifloxacin composition |
| ES2358682T3 (es) * | 2005-08-02 | 2011-05-12 | Baxter International Inc. | Recipientes de múltiples cámaras. |
| WO2007067416A2 (en) * | 2005-12-05 | 2007-06-14 | Affinium Pharmaceuticals, Inc. | Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents |
| EP2687533B1 (en) | 2006-07-20 | 2017-07-19 | Debiopharm International SA | Acrylamide derivatives as FAB I inhibitors |
| CN100415212C (zh) * | 2006-07-21 | 2008-09-03 | 哈药集团制药总厂 | 一种含乳酸卡德沙星的口服制剂 |
| CA2563690C (en) * | 2006-10-12 | 2014-10-07 | Pharmascience Inc. | Pharmaceutical compositions comprising intra- and extra- granular fractions |
| EP2125802A4 (en) | 2007-02-16 | 2014-08-20 | Debiopharm Int Sa | SALTS, PRODRUGS AND POLYMORPHES OF FAB I INHIBITORS |
| RS58898B1 (sr) | 2012-06-19 | 2019-08-30 | Debiopharm Int Sa | Prolek derivati (e)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamida |
| LT3419628T (lt) | 2016-02-26 | 2021-01-25 | Debiopharm International Sa | Medikamentas diabetinėms pėdų infekcijoms gydyti |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH089597B2 (ja) * | 1986-01-21 | 1996-01-31 | 杏林製薬株式会社 | 選択毒性に優れた８‐アルコキシキノロンカルボン酸およびその塩並びにその製造方法 |
| PL169106B1 (pl) * | 1991-01-30 | 1996-06-28 | Wellcome Found | Sposób wytwarzania dyspergowalnej w wodzie tabletki PL PL PL PL PL PL PL |
| GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
| US5436253A (en) * | 1993-09-08 | 1995-07-25 | Daiichi Pharmaceutical Co., Ltd. | Pyridonecarboxylic acid derivatives and mycotic infections |
| EP0797987B1 (en) * | 1994-12-19 | 2003-10-15 | Daiichi Pharmaceutical Co., Ltd. | Sustained-release granular preparation and process for producing the same |
| US5945124A (en) * | 1995-07-05 | 1999-08-31 | Byk Gulden Chemische Fabrik Gmbh | Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole |
| US5837292A (en) * | 1996-07-03 | 1998-11-17 | Yamanouchi Europe B.V. | Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug |
-
1998
- 1998-05-09 DE DE19820801A patent/DE19820801A1/de not_active Withdrawn
-
1999
- 1999-04-22 MY MYPI99001588A patent/MY118569A/en unknown
- 1999-04-29 UA UA2000126915A patent/UA60364C2/uk unknown
- 1999-04-29 AT AT99923491T patent/ATE235242T1/de not_active IP Right Cessation
- 1999-04-29 PL PL99343936A patent/PL343936A1/xx unknown
- 1999-04-29 WO PCT/EP1999/002893 patent/WO1999058129A1/de active IP Right Grant
- 1999-04-29 HU HU0101597A patent/HUP0101597A3/hu unknown
- 1999-04-29 CA CA002325636A patent/CA2325636A1/en not_active Abandoned
- 1999-04-29 DK DK99923491T patent/DK1077703T3/da active
- 1999-04-29 EP EP99923491A patent/EP1077703B1/de not_active Expired - Lifetime
- 1999-04-29 JP JP2000547980A patent/JP2002514600A/ja active Pending
- 1999-04-29 SK SK1677-2000A patent/SK16772000A3/sk unknown
- 1999-04-29 NZ NZ507968A patent/NZ507968A/xx unknown
- 1999-04-29 DE DE59904737T patent/DE59904737D1/de not_active Expired - Fee Related
- 1999-04-29 IL IL13951299A patent/IL139512A0/xx unknown
- 1999-04-29 PT PT99923491T patent/PT1077703E/pt unknown
- 1999-04-29 ES ES99923491T patent/ES2195573T3/es not_active Expired - Lifetime
- 1999-04-29 KR KR1020007012442A patent/KR100587210B1/ko not_active IP Right Cessation
- 1999-04-29 BR BR9910350-8A patent/BR9910350A/pt not_active IP Right Cessation
- 1999-04-29 AU AU40352/99A patent/AU753482B2/en not_active Ceased
- 1999-04-29 CN CNB998059897A patent/CN1198615C/zh not_active Expired - Fee Related
- 1999-04-29 US US09/700,055 patent/US6291462B1/en not_active Expired - Fee Related
- 1999-04-29 RU RU2000130202/15A patent/RU2226394C2/ru not_active IP Right Cessation
- 1999-05-03 PE PE1999000361A patent/PE20000480A1/es not_active Application Discontinuation
- 1999-05-04 CO CO99027132A patent/CO5050341A1/es unknown
- 1999-05-07 AR ARP990102177A patent/AR019279A1/es active IP Right Grant
-
2000
- 2000-10-26 NO NO20005385A patent/NO20005385L/no not_active Application Discontinuation
- 2000-11-08 ZA ZA200006440A patent/ZA200006440B/en unknown
-
2001
- 2001-06-14 HK HK01104097A patent/HK1033281A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| SK16772000A3 (sk) | 2001-05-10 |
| CA2325636A1 (en) | 1999-11-18 |
| CN1300216A (zh) | 2001-06-20 |
| UA60364C2 (uk) | 2003-10-15 |
| HUP0101597A3 (en) | 2003-01-28 |
| RU2226394C2 (ru) | 2004-04-10 |
| KR100587210B1 (ko) | 2006-06-08 |
| AU753482B2 (en) | 2002-10-17 |
| DE59904737D1 (de) | 2003-04-30 |
| HK1033281A1 (en) | 2001-08-24 |
| MY118569A (en) | 2004-12-31 |
| PT1077703E (pt) | 2003-08-29 |
| PL343936A1 (en) | 2001-09-10 |
| EP1077703B1 (de) | 2003-03-26 |
| IL139512A0 (en) | 2001-11-25 |
| JP2002514600A (ja) | 2002-05-21 |
| DE19820801A1 (de) | 1999-11-25 |
| HUP0101597A2 (hu) | 2001-11-28 |
| CN1198615C (zh) | 2005-04-27 |
| ZA200006440B (en) | 2002-02-08 |
| KR20010043408A (ko) | 2001-05-25 |
| BR9910350A (pt) | 2001-09-25 |
| DK1077703T3 (da) | 2003-06-23 |
| AU4035299A (en) | 1999-11-29 |
| NO20005385D0 (no) | 2000-10-26 |
| NZ507968A (en) | 2002-12-20 |
| US6291462B1 (en) | 2001-09-18 |
| PE20000480A1 (es) | 2000-05-20 |
| NO20005385L (no) | 2000-10-26 |
| ES2195573T3 (es) | 2003-12-01 |
| EP1077703A1 (de) | 2001-02-28 |
| WO1999058129A1 (de) | 1999-11-18 |
| ATE235242T1 (de) | 2003-04-15 |
| CO5050341A1 (es) | 2001-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR019279A1 (es) | Forma medicamentosa solida de estructura polifasica para la aplicacion oral que contiene gatifloxacina o sus sales o hidratos farmaceuticamente aplicables, y procedimiento para su preparacion. | |
| CY1122582T1 (el) | Στερεες μορφες δοσολογιας περιλαμβανουν εντερικη επικαλυψη με επιταχυνομενη απελευθερωση φαρμακου | |
| AR035500A1 (es) | Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina. | |
| ES2175127T3 (es) | Derivados de la quinazolina y su uso. | |
| ES2207298T3 (es) | Nuevos esteres derivados de compuestos fenil-ciclohexil substituidos. | |
| SV2002000169A (es) | Nuevos derivados del acido aminodicarboxilico con propiedades farmaceuticas ref. lea 33878-sv | |
| AP1445A (en) | Substituted 4-amino-thiazol-2-yl compounds as CDKs inhibitors. | |
| AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
| CO5011096A1 (es) | Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs | |
| CY1105538T1 (el) | Ιατρικη μορφοποιηση αερολυματος | |
| UY27417A1 (es) | Compuestos bicíclicos aromáticos sustituidos con amino-alquilo, procedimiento para su preparación y su utilización como medicamentos | |
| BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| MX9204625A (es) | Composicion farmaceutica para el tratamiento de una especie de mamifero, que sufre de deficiencia cardiaca congestiva. | |
| UY27474A1 (es) | Formulación de dosificación oral de fusion instantanea. | |
| ECSP034534A (es) | Nuevos tiadiazoles y oxadiazoles y su uso como inhibidores de fosfodiesterasa-7 | |
| PT991654E (pt) | Novos derivados de 2-(iminometil)amino-fenilo sua preparacao sua aplicacao como medicamentos e composicoes farmaceuticas que os contem | |
| HN2004000109A (es) | Nueva difenilazetidinona con propiedades fisiologicas mejoradas, procedimiento para su preparacion, medicamentos que comprenden este compuesto y su uso | |
| BRPI0415053A (pt) | inibidor de p-glicoproteìna, método para preparar o mesmo e composição farmacêutica que compreende o mesmo | |
| ECSP045498A (es) | "difenilazetidinonas sustituidas en anillo, metodo para su producción, medicamentos que comprenden estos compuestos y su uso" | |
| BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
| CL2015001086A1 (es) | Combinación farmacéutica para el tratamiento y/o quimiosensibilizacion de tumores refractarios a drogas anticancerigenas | |
| HN2009000968A (es) | Compuestos de pirazol y triazol sustituidos como inhibidores de ksp | |
| AR024462A1 (es) | Tabletas farmaceuticas | |
| PT1140031E (pt) | Preparacao farmaceutica de libertacao controlada com mesilato de tilidina como substancia activa | |
| AR032989A1 (es) | Una composicion farmaceutica util para el tratamiento del cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration |